Sign in Sign Up Free

Biotechnology Value Fund, L.P.

Activist investor & 5%+ owner · SC 13D/13G filings

Total Filings

213

Stocks Covered

84

Latest Filing

Dec 17, 2024

Filings

Cullinan Oncology, Inc.

SC 13G/A · Feb 14, 2024

6.5%

2.9M shares

Centessa Pharmaceuticals plc

SC 13G/A · Feb 14, 2024

4.7%

4.6M shares

Crinetics Pharmaceuticals, Inc.

SC 13G/A · Feb 14, 2024

0.0%

0 shares

CytomX Therapeutics, Inc.

SC 13G/A · Feb 14, 2024

5.4%

3.7M shares

Delcath Systems, Inc.

SC 13G/A · Feb 14, 2024

6.2%

1.4M shares

Eledon Pharmaceuticals, Inc.

SC 13G/A · Feb 14, 2024

9.6%

2.3M shares

Elevation Oncology, Inc.

SC 13G/A · Feb 14, 2024

7.5%

3.3M shares

89bio, Inc.

SC 13G/A · Feb 14, 2024

4.2%

4.0M shares

4D Molecular Therapeutics, Inc.

SC 13G/A · Feb 14, 2024

5.0%

2.1M shares

GH Research PLC

SC 13G/A · Feb 14, 2024

10.4%

5.4M shares

N/A

Galmed Pharmaceuticals Ltd.

SC 13G/A · Feb 14, 2024

0.0%

0 shares

IDEAYA Biosciences, Inc.

SC 13G/A · Feb 14, 2024

2.8%

1.8M shares

Ikena Oncology, Inc.

SC 13G/A · Feb 14, 2024

5.1%

2.5M shares

iTeos Therapeutics, Inc.

SC 13G/A · Feb 14, 2024

1.9%

672K shares

Janux Therapeutics, Inc.

SC 13G/A · Feb 14, 2024

5.3%

2.4M shares

Jasper Therapeutics, Inc.

SC 13G/A · Feb 14, 2024

0.0%

0 shares

Kura Oncology, Inc.

SC 13G/A · Feb 14, 2024

5.1%

3.8M shares

Lexicon Pharmaceuticals, Inc.

SC 13G/A · Feb 14, 2024

5.1%

12.6M shares

Merus N.V.

SC 13G/A · Feb 14, 2024

2.5%

1.5M shares

Molecular Templates, Inc.

SC 13G/A · Feb 14, 2024

5.4%

289K shares

Protagonist Therapeutics, Inc.

SC 13G/A · Feb 14, 2024

5.4%

3.1M shares

Pyxis Oncology, Inc.

SC 13G/A · Feb 14, 2024

0.0%

0 shares

Revolution Medicines, Inc.

SC 13G/A · Feb 14, 2024

1.9%

3.1M shares

Tyra Biosciences, Inc.

SC 13G/A · Feb 14, 2024

3.4%

1.5M shares

Viridian Therapeutics, Inc.

SC 13G/A · Feb 14, 2024

0.0%

0 shares

Verastem, Inc.

SC 13G/A · Feb 14, 2024

5.4%

1.4M shares

GlycoMimetics, Inc.

SC 13G/A · Jan 29, 2024

7.7%

5.0M shares

Allakos Inc.

SC 13G/A · Jan 18, 2024

9.9%

8.7M shares

Allakos Inc.

SC 13G/A · Jan 18, 2024

5.2%

4.6M shares

Immunic, Inc.

SC 13G · Jan 18, 2024

5.2%

4.7M shares

POINT Biopharma Global Inc.

SC 13D/A · Dec 20, 2023

0.0%

0 shares

Structure Therapeutics Inc.

SC 13G/A · Dec 20, 2023

1.0%

1.3M shares

AC Immune SA

SC 13G/A · Dec 19, 2023

7.7%

7.7M shares

SAB Biotherapeutics, Inc.

SC 13G · Dec 4, 2023

5.3%

4.9M shares

Molecular Partners AG

SC 13D · Nov 20, 2023

12.3%

4.5M shares

Repare Therapeutics Inc.

SC 13D/A · Nov 17, 2023

12.6%

5.3M shares

enGene Holdings, Inc.

SC 13G · Nov 13, 2023

7.2%

1.7M shares

Molecular Partners AG

SC 13G/A · Nov 7, 2023

9.2%

3.3M shares

POINT Biopharma Global Inc.

SC 13D · Nov 6, 2023

8.5%

9.0M shares

Repare Therapeutics Inc.

SC 13D · Nov 3, 2023

11.1%

4.7M shares

Vistagen Therapeutics, Inc.

SC 13G · Oct 16, 2023

5.2%

1.4M shares

Mirum Pharmaceuticals, Inc.

SC 13G · Sep 18, 2023

5.0%

2.3M shares

Pieris Pharmaceuticals, Inc.

SC 13D/A · Aug 17, 2023

11.1%

11.0M shares

Forte Biosciences, Inc.

SC 13G · Aug 10, 2023

4.4%

1.6M shares

Unicycive Therapeutics, Inc.

SC 13G · Jul 6, 2023

5.3%

1.9M shares

Revolution Medicines, Inc.

SC 13G · Jun 30, 2023

4.4%

4.6M shares

Delcath Systems, Inc.

SC 13G · Jun 22, 2023

6.5%

1.0M shares

TScan Therapeutics, Inc.

SC 13G · Jun 5, 2023

6.8%

3.0M shares

Janux Therapeutics, Inc.

SC 13G · May 30, 2023

5.2%

2.2M shares

Pieris Pharmaceuticals, Inc.

SC 13D · May 22, 2023

11.8%

11.0M shares